The Team
![Photo of Charles Richardson PhD, Founder, President, and CEO of TollereBio.](https://assets-global.website-files.com/656e7e643a7d5b358aa1276b/656e7e643a7d5b358aa12778_scientist-1.png)
Charles Richardson PhD
Founder, President and CEO
- 30+ years in vaccine and adjuvant development
- SVP CMC/Tech Ops, Icosavax
- Global Head CMC, Takeda Vaccines
- SVP R&D, LigoCyte
- VP & Site Head, Corxia
- VP Pharma Discovery, Ribi ImmunoChem
![Photo of Robert K. Ernst, PhD, Founder and SAB Chair of TollereBio.](https://assets-global.website-files.com/656e7e643a7d5b358aa1276b/656e7e643a7d5b358aa12779_scientist-2.png)
Robert K. Ernst PhD
Founder and SAB Chair
- 10+ years of experience in vaccine and adjuvant research
- Inventor of BECC platform for use as vaccine adjuvants (anything about anti-sepsis)
- Dr. Paul and Mrs. Jean Corcoran Endowed Professor at University of Maryland, Baltimore
- Chair of the Department of Microbial Pathogenesis
- Distinguished University Professor
- Co-Founder of Pataigin LLC developing a rapid lipid-based diagnostic platform
![Photo of Hans Lien, Founder and COO of TollereBio.](https://assets-global.website-files.com/656e7e643a7d5b358aa1276b/656e7e643a7d5b358aa1277a_scientist-3.png)
Hans Lien
Founder and COO
- 25+ years in vaccine and adjuvant development
- VP Quality, Icosavax
- Global Head CMC QA/QC, Takeda Vaccines
- Director QA, LigoCyte
- Manager QA, Schering-Plough Animal Health (now MSD)
- Manager Upstream Mfg, GSK, Corixa, Ribi ImmunoChem